Trial intelligence / Profile preview

Flunarizine vs Propranolol in Pediatric Migraine

NCT07354126Recruiting

Start
Sep 2025
Primary completion
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Trial of flunarizine and propranolol in migraine (2 arms). Primary endpoint: Pediatric Migraine Disability Assessment Scale score reduction at 3 months. Started Sep 2025; status: recruiting.

02

Drugs

flunarizinepropranolol
03

Conditions

migraine

Beyond the preview

Go deeper on NCT07354126.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07354126.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call